These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. What is a dose of ecstasy? Cole JC; Sumnall HR; Wagstaff GF J Psychopharmacol; 2002 Jun; 16(2):189-90. PubMed ID: 12095080 [No Abstract] [Full Text] [Related]
3. Adverse symptomatology and suicide associated with the use of methylenedioxymethamphetamine (MDMA; "Ecstasy"). Cohen RS Biol Psychiatry; 1996 May; 39(9):819-20. PubMed ID: 8731525 [No Abstract] [Full Text] [Related]
4. Selective neurocognitive deficits associated with multiple doses of ecstasy/MDMA: a reply to Cole. Fox HC; Parrott AC J Psychopharmacol; 2003 Jun; 17(2):242-4. PubMed ID: 12870575 [No Abstract] [Full Text] [Related]
5. Neurological and psychopathological sequelae associated with a lifetime intake of 40,000 ecstasy tablets. Kouimtsidis C; Schifano F; Sharp T; Ford L; Robinson J; Magee C Psychosomatics; 2006; 47(1):86-7. PubMed ID: 16384814 [No Abstract] [Full Text] [Related]
6. [The new drugs: ecstasy, GHB. Update for practitioners]. Feldman N; Croquette-Krokar M Rev Med Suisse Romande; 2001 Dec; 121(12):885-8. PubMed ID: 11803792 [No Abstract] [Full Text] [Related]
7. [Effects of ecstasy on the body]. Saarijärvi S; Lopperi M Duodecim; 2003; 119(13):1211-5. PubMed ID: 12908183 [No Abstract] [Full Text] [Related]
8. [Ecstasy is a dangerous drug the society chooses to ignore]. Heilig M Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555 [No Abstract] [Full Text] [Related]
9. Modelling the adverse effects associated with ecstasy use. Fisk JE; Murphy PN; Montgomery C; Hadjiefthyvoulou F Addiction; 2011 Apr; 106(4):798-805. PubMed ID: 21182557 [TBL] [Abstract][Full Text] [Related]
10. MDMA: fact and fallacy, and the need to increase knowledge in both the scientific and popular press. Green AR Psychopharmacology (Berl); 2004 May; 173(3-4):231-3. PubMed ID: 14985917 [No Abstract] [Full Text] [Related]
13. The reality of psychomotor problems, and the possibility of Parkinson's disorder, in some recreational ecstasy/MDMA users: a rejoinder to Sumnall et al. (2003). Parrott AC; Rodgers J; Buchanan T; Scholey AB; Heffernan T; Ling J Psychopharmacology (Berl); 2004 Jan; 171(2):231-3. PubMed ID: 14634710 [No Abstract] [Full Text] [Related]
14. [Ecstasy-induced fulminant hepatic failure and emergency liver transplantation]. Carrión JA; Escorsell A; Nogué S; Mas A Med Clin (Barc); 2003 Jun; 121(3):118-9. PubMed ID: 12855141 [No Abstract] [Full Text] [Related]
16. Criminal involvement among young male ecstasy users. Hendrickson JC; Gerstein DR Subst Use Misuse; 2005; 40(9-10):1557-75. PubMed ID: 16048833 [TBL] [Abstract][Full Text] [Related]
17. Acute myelopathy selectively involving lumbar anterior horns following intranasal insufflation of ecstasy and heroin. Riva N; Morana P; Cerri F; Gerevini S; Amadio S; Formaglio F; Comi G; Comola M; Del Carro U J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):908-9. PubMed ID: 17635986 [No Abstract] [Full Text] [Related]
18. MDMA ("ecstasy") and neurotoxicity. Mithoefer M; Jerome L; Doblin R Science; 2003 Jun; 300(5625):1504-5; author reply 1504-5. PubMed ID: 12791964 [No Abstract] [Full Text] [Related]